AUTS2
protein-codingactivator of transcription and developmental regulator AUTS2
Gene summary
This gene has been implicated in neurodevelopment and as a candidate gene for numerous neurological disorders, including autism spectrum disorders, intellectual disability, and developmental delay. Mutations in this gene have also been associated with non-neurological disorders, such as acute lymphoblastic leukemia, aging of the skin, early-onset androgenetic alopecia, and certain cancers. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~1,195.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0014361
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014361
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014361
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0000508
Submitter: ClinGen
Variants in the AUTS2 gene were first reported in multiple individuals with syndromic intellectual disability in 2013 (Beunders et al. 2013, PMID: 23332918). Affected individuals present with intellectual disability, microcephaly, feeding problems, and mild dysmorphic features. Numerous variants including genomic rearrangements, whole-gene deletions, intragenic deletions and duplications, and loss of function sequence variants have been described (PMID: 22872102, 23650183, 26545289, and 24459036). The mechanism for disease is haploinsufficiency. This gene-disease relationship is supported by animal models, rescue experiments, and expression studies. In summary, AUTS2 is definitively associated with syndromic intellectual disability. This classification was approved by the ClinGen Intellectual Disability and Autism Working Group on 09/01/2020 (SOP Version 7).
Inheritance Pattern: AD
Disease ID:MONDO:0014361
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AUTS2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015570.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 226 | 18 | 253 | ||
| missense | 3 | 12 | 499 | 137 | 37 | 688 |
| nonsense | 14 | 11 | 3 | 1 | 29 | |
| start loss | 3 | 1 | 4 | |||
| frameshift | 35 | 17 | 8 | 1 | 61 | |
| splice donor/acceptor (+/-2bp) | 8 | 7 | 8 | 23 | ||
| Total | 63 | 48 | 527 | 365 | 55 | 1058 |
Highest pathogenic variant AF is 0.000008673418
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_056385.1 | 19 | MANE Select | |
| Ensembl | ENSP00000344087.4 | 19 | MANE Select | |
| RefSeq | NP_001120703.1 | 18 | Standard | |
| RefSeq | NP_001120704.1 | 5 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| auts2a | Danio rerio | Structure: motor neuron Quality: decreased size abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gene expression (Transcription)
- RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
- Generic Transcription Pathway
- RNA Polymerase II Transcription
- Transcriptional regulation by RUNX1
Biological Process
- neuron migration
- biological_process
- positive regulation of lamellipodium assembly
- forebrain neuron development
- actin cytoskeleton reorganization
Molecular Function
- molecular_function
- chromatin binding
- protein binding
Cellular Component
- cellular_component
- nucleus
- cytoplasm
- actin cytoskeleton
- growth cone
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000342771
- Coding exons
- 19
- Length
- 1194150
- Individuals with no LoFs
- 125742
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 6
- Defined
- 125748
- p
- 0.0000239
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.22 | 617 | 793 | 0.778 | 0.0000512 | 8156 |
| Missense (PolyPhen) | 253 | 375.2 | 0.67431 | 3698 | ||
| Synonymous | -1.17 | 362 | 335 | 1.08 | 0.0000233 | 2614 |
| Loss of Function | 5.78 | 7 | 52.0 | 0.135 | 0.00000292 | 553 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000036 | 0.000035 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of a Polycomb group (PcG) multiprotein PRC1- like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:25519132). The PRC1-like complex that contains PCGF5, RNF2, CSNK2B, RYBP and AUTS2 has decreased histone H2A ubiquitination activity, due to the phosphorylation of RNF2 by CSNK2B (PubMed:25519132). As a consequence, the complex mediates transcriptional activation (PubMed:25519132). In the cytoplasm, plays a role in axon and dendrite elongation and in neuronal migration during embryonic brain development. Promotes reorganization of the actin cytoskeleton, lamellipodia formation and neurite elongation via its interaction with RAC guanine nucleotide exchange factors, which then leads to the activation of RAC1 (By similarity). {ECO:0000250|UniProtKB:A0A087WPF7, ECO:0000269|PubMed:25519132}.;
- Disease
- DISEASE: Mental retardation, autosomal dominant 26 (MRD26) [MIM:615834]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Additional MRD26 features include autism, short stature, microcephaly, cerebral palsy, and facial dysmorphisms. {ECO:0000269|PubMed:23332918}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- LoFtool
- 0.317
- RVIS EVS
- -1.97
- RVIS percentile EVS
- 1.82
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0988
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |